Namenda is the brand name for the drug memantine a medication used to treat moderate to severe alzheimer's disease. It works by blocking nmda receptors in the brain which helps to regulate the activity of glutamate and prevent excessive neuronal stimulation. By modulating glutamatergic signaling the drug reduces the risk of neurotoxic damage that contributes to cognitive decline. The therapeutic role of Namenda is to improve cognitive function and daily living activities in patients experiencing memory loss. The drug is administered orally in tablet form and is typically taken once daily with dosage adjusted based on patient response. Its pharmacological effect is primarily due to its dose-dependent antagonism of nmda receptors providing a protective effect on brain cells.

Namenda is the brand name for memantine a medication used to treat moderate to severe alzheimer's disease. It belongs to the class of nmda receptor antagonists that modulate glutamatergic neurotransmission. By inhibiting excessive nmda receptor activity the drug reduces excitotoxic calcium influx that contributes to neuronal damage. This action helps preserve synaptic function and slows cognitive decline in patients with the disease. The medication is administered orally and provides systemic exposure that allows consistent receptor modulation throughout the central nervous system. Its therapeutic effect is achieved through attenuation of abnormal glutamate signaling which improves memory and daily functioning while maintaining an overall neutral impact on other neurotransmitter systems.

Some patients may experience dizziness after starting Namenda. Headache and confusion are also reported as frequent side effects. Fatigue or unusual tiredness can occur without a clear cause. Nausea and constipation are common gastrointestinal responses. In rare cases, memory disturbances or mood changes have been noted. Most of these effects are mild to moderate and often improve with continued use. Side effects often lessen as the body adjusts to the medication.

Some people may experience dizziness when taking Namenda. Headaches are also reported as a frequent side effect. Confusion or disorientation can occur in certain individuals. Constipation is a common gastrointestinal reaction. Nausea may develop shortly after starting the medication. Elevated blood pressure has been observed in some patients. Fatigue or a feeling of tiredness is often mentioned. Rarely, individuals may notice swelling in the lower extremities.